From announcement 9th May 2011, 'Further, the Company is advised...

From announcement 9th May 2011, 'Further, the Company is advised that a number of the proposed Indian subscribers to the TeleMedCare special purpose Indian company are also desirous of investing in Stirling Products in order to get direct exposure to the global TeleMedCare and High Density Aerosol(HDA) pulmonary drug delivery opportunity. The LOI has therefore conditionally provided for a subscription to the issue of a total 880 million shares in Stirling Products in consideration of the payment of AUD$5 million (an average of $0.0056 per share)'.

Now we intend to raise the cash in the UK, a country atm that has severe financial problems.

According to this announcement we were prepared to flog almost 1/3 of the company for 5 mil yet we stated today that we dont want involvement from majors with the HDA.